Proprio, a surgical visualization technology company, raised a $43 million Series B to bring its FDA-cleared platform to market, CEO Gabriel Jones tells Axios.
Why it matters: A persistent shortage of surgeons has increased the need for technology that saves time and makes operating room workflows more efficient.
